检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment.

Peter Kamenicky,Karine Briot,Maria Luisa Brandi,Martine Cohen-Solal,Rachel K Crowley,Richard Keen,Sami Kolta,Robin H Lachmann,Anne-Lise Lecoq,Stuart H Ralston,Jennifer S Walsh,Angela J Rylands,Angela Williams,Wei Sun,Annabel Nixon,Mark Nixon,Muhammad K Javaid

RMD open（2023）

引用 0|浏览27
暂无评分
摘要
Phase 3: NCT02526160; open-label extension: NCT03920072.
更多
查看译文
关键词
Outcome Assessment, Health Care,Patient Reported Outcome Measures,Therapeutics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要